Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMOSMBZ)

Drug Name

PMID24900824C2-1-1 Drug Info

Synonyms

GTPL8109; BDBM50011209

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting BUB1 mitotic checkpoint serine/threonine kinase (BUB1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
SCHEMBL16322760	DM3OB4T	N. A.	N. A.	Patented	[2]
SCHEMBL17766424	DMC7PTY	N. A.	N. A.	Patented	[2]
SCHEMBL16365841	DMQARW2	N. A.	N. A.	Patented	[2]
PMID24900824C2-13-1	DM2FYUM	Discovery agent	N.A.	Investigative	[1]
PMID24900824C2-3-1	DMC5JAT	Discovery agent	N.A.	Investigative	[1]
PMID24900824C2-3-2	DMVP0Z9	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
BUB1 mitotic checkpoint serine/threonine kinase (BUB1)	TT78309	BUB1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Novel cycloalkenepyrazoles as inhibitors of bub1 kinase. ACS Med Chem Lett. 2014 Feb 12;5(4):280-1.
2	Substituted benzylpyrazoles. US9765058.